(Q53216024)

12 May 2018

title

Lymphocytopenia as a prognostic marker for diffuse large B cell lymphomas. (English)

1 reference

12 May 2018

1

Dipti Talaulikar

1 reference

12 May 2018

author name string

Ayesha Choudhury

series ordinal

2

1 reference

12 May 2018

Bruce Shadbolt

series ordinal

3

1 reference

12 May 2018

Michael Brown

series ordinal

4

1 reference

12 May 2018

publication date

1 May 2008

1 reference

12 May 2018

published in

Leukemia & Lymphoma

1 reference

12 May 2018

volume

49

1 reference

12 May 2018

issue

5

1 reference

12 May 2018

page(s)

959-964

1 reference

12 May 2018

State-of-the-art therapeutics: diffuse large B-cell lymphoma

cites work

1 reference

https://api.crossref.org/works/10.1080%2F10428190801959026

Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190801959026

Introduction of combined CHOP plus rituximab therapy dramatically improved outcome of diffuse large B-cell lymphoma in British Columbia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190801959026

A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190801959026

Absolute lymphocyte count predicts overall survival in follicular lymphomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190801959026

The International Prognostic Factors Project score for advanced Hodgkin's disease is useful for predicting outcome of autologous hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190801959026

Identification of patients at risk for early death after conventional chemotherapy in solid tumours and lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190801959026

Assessment of the efficacy of total lymphocyte counts as predictors of AIDS defining infections in HIV-1 infected people

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190801959026

Tumor-driven evolution of immunosuppressive networks during malignant progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190801959026

Early lymphopenia as a risk factor for chemotherapy-induced febrile neutropenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190801959026

Baseline and early lymphopenia predict for the risk of febrile neutropenia after chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190801959026

From the bench to the bedside: ways to improve rituximab efficacy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190801959026

Profound lymphopenia and bacteraemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190801959026

Absolute lymphocyte count recovery after induction chemotherapy predicts superior survival in acute myelogenous leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190801959026

10.1080/10428190801959026

21 January 2018

Identifiers

DOI

1 reference

12 May 2018

1 reference

12 May 2018